Rosalind M Eggo
Overview
Explore the profile of Rosalind M Eggo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
10622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Williamson E, Tazare J, Bhaskaran K, Walker A, McDonald H, Tomlinson L, et al.
Wellcome Open Res
. 2025 Feb;
5:243.
PMID: 39931522
On March 11th 2020, the World Health Organization characterised COVID-19 as a pandemic. Responses to containing the spread of the virus have relied heavily on policies involving restricting contact between...
2.
van Zandvoort K, Hassan A, Bobe M, Pell C, Ahmed M, Ortika B, et al.
Pneumonia (Nathan)
. 2024 Dec;
16(1):25.
PMID: 39633426
Background: Populations affected by humanitarian crises likely experience high burdens of pneumococcal disease. Streptococcus pneumoniae carriage estimates are essential to understand pneumococcal transmission dynamics and the potential impact of pneumococcal...
3.
Procter S, Waterlow N, Radhakrishnan S, van Leeuwen E, Meeyai A, Cooper B, et al.
BMJ Glob Health
. 2024 Nov;
9(11).
PMID: 39557448
Introduction: Thailand was one of the first low- and middle-income countries to publicly fund seasonal influenza vaccines, but the lack of predictability in the timing of epidemics and difficulty in...
4.
Watson C, Gsell P, Hall Y, Camacho A, Riveros X, Enwere G, et al.
BMC Med
. 2024 Nov;
22(1):523.
PMID: 39511527
Background: Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas may have pre-existing antibodies from asymptomatic Ebolavirus exposure that...
5.
Prem K, van Zandvoort K, Klepac P, Eggo R, Davies N
PLoS Comput Biol
. 2024 Sep;
20(9):e1012454.
PMID: 39292734
[This corrects the article DOI: 10.1371/journal.pcbi.1009098.].
6.
Lin L, Henderson A, Carlile O, Dillingham I, Butler-Cole B, Marks M, et al.
BMC Med
. 2024 Jun;
22(1):255.
PMID: 38902726
Background: Long COVID potentially increases healthcare utilisation and costs. However, its impact on the NHS remains to be determined. Methods: This study aims to assess the healthcare utilisation of individuals...
7.
Henderson A, Butler-Cole B, Tazare J, Tomlinson L, Marks M, Jit M, et al.
EClinicalMedicine
. 2024 May;
72:102638.
PMID: 38800803
Background: Long COVID is the patient-coined term for the persistent symptoms of COVID-19 illness for weeks, months or years following the acute infection. There is a large burden of long...
8.
Sherratt K, Carnegie A, Kucharski A, Cori A, Pearson C, Jarvis C, et al.
Wellcome Open Res
. 2024 May;
9:12.
PMID: 38784437
Background: The COVID-19 pandemic both relied and placed significant burdens on the experts involved from research and public health sectors. The sustained high pressure of a pandemic on responders, such...
9.
Carlile O, Briggs A, Henderson A, Butler-Cole B, Tazare J, Tomlinson L, et al.
Lancet Reg Health Eur
. 2024 May;
40:100908.
PMID: 38689605
Background: Long COVID is a major problem affecting patient health, the health service, and the workforce. To optimise the design of future interventions against COVID-19, and to better plan and...
10.
Goodfellow L, van Leeuwen E, Eggo R
BMC Med
. 2024 Apr;
22(1):162.
PMID: 38616257
Background: The COVID-19 pandemic resulted in major inequalities in infection and disease burden between areas of varying socioeconomic deprivation in many countries, including England. Areas of higher deprivation tend to...